Literature DB >> 2025307

Diversity of rheumatoid synovial tissue T cells by T cell receptor analysis. Oligoclonal expansion in interleukin-2-responsive cells.

S M Cooper1, D L Dier, K D Roessner, R C Budd, J A Nicklas.   

Abstract

The synovitis of rheumatoid arthritis (RA) is characterized by infiltrates of CD4+ T lymphocytes. To determine the clonal diversity of these cells, we cloned T cells with interleukin-2 (IL-2), alone or with phytohemagglutinin (PHA), directly from actively inflamed synovial tissue obtained at synovectomy. A total of 205 clones from 4 specimens was analyzed for T cell receptor (TCR) gene rearrangements using Hind III and Eco RI digests with beta chain and gamma chain complementary DNA probes. A comparison of the TCR rearrangements enabled us to determine if the T cell clones arose from the same or different precursor cells. Most of the T cell clones (92%) had distinct TCR gene rearrangement patterns, indicating a unique clonal origin. However, a few clones (1 quadruplicate and 6 pairs) with identical TCR rearrangements were identified, and these clonal multiples were most commonly found in clones selected with IL-2 alone. Mass cultures were propagated with IL-2, alone or with PHA, and at each passage, cells were removed for TCR analysis. The later passages of the lines selected with IL-2 had oligoclonal TCR rearrangements, whereas no oligoclonal rearrangements were found in the PHA + IL-2-selected cell lines. The TCR rearrangements in the later passages of the IL-2 mass cultures were often identical to the TCR rearrangements that were found in the IL-2-derived clonal multiples. These findings indicate that while the majority of CD4+ T cells within the actively inflamed rheumatoid joint have diverse clonal origins, small numbers of clonal multiples and oligoclonal populations are present, and these cells may be enriched in an IL-2-responsive T cell subset.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025307     DOI: 10.1002/art.1780340505

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 2.  Synovial lymphocytes and the aetiology of synovitis.

Authors:  H Gaston
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

3.  Lack of preferential V beta usage in synovial T cells of rheumatoid arthritis patients.

Authors:  F Dedeoglu; H Kaymaz; N Seaver; S F Schluter; D E Yocum; J J Marchalonis
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  T cell receptor analysis in rheumatoid arthritis: what have we learnt?

Authors:  S H Zwillich; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

5.  T cell receptor V beta gene bias in rheumatoid arthritis.

Authors:  R N Jenkins; A Nikaein; A Zimmermann; K Meek; P E Lipsky
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Clonality of T lymphocytes expanded with IL-2 from rheumatoid arthritis peripheral blood, synovial fluid and synovial membrane.

Authors:  A Cantagrel; A Alam; H L Coppin; B Mazieres; C De Preval
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

7.  Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis.

Authors:  A A Grom; S D Thompson; L Luyrink; M Passo; E Choi; D N Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease.

Authors:  R Gerli; O Bistoni; A Russano; S Fiorucci; L Borgato; M E F Cesarotti; C Lunardi
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

9.  Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis.

Authors:  A Kuryliszyn-Moskal
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.